In the pipeline: new oral anticoagulants for the prevention of venous thromboembolism.
Farley
T Michael
TM
Department of Pharmacy Services, UK HealthCare, University of Kentucky College of Pharmacy, Pharmacy Practice and Science, Lexington, Kentucky 40536-0293, USA.
Lewis
Daniel
D
Macaulay
Tracy E
TE
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000008:administration & dosage*; D002986:Clinical Trials as Topic / Q000639:trends*; D000069604:Dabigatran; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage*; D011720:Pyrazoles / Q000008:administration & dosage*; D011725:Pyridines / Q000008:administration & dosage*; D011728:Pyridones / Q000008:administration & dosage*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000008:administration & dosage*; D054556:Venous Thromboembolism / Q000188:drug therapy*
D000925:Anticoagulants; D001562:Benzimidazoles; D005343:Fibrinolytic Agents; D009025:Morpholines; D011720:Pyrazoles; D011725:Pyridines; D011728:Pyridones; D013876:Thiophenes; C522181:apixaban; D000069552:Rivaroxaban; D000069604:Dabigatran